Federal Register / Vol. 72, No. 27 / Friday, February 9, 2007 / Notices 6247 

There are no costs to the respondents 

other than their time. The total 

estimated annualized burden hours are 

234. 

Type of responses or kinds of respondents Number of respondents 

Number of responses per 

respondent 

Average burden per response (in 

hours) 

Semi-Annual Report .................................................................................................................... 13 2 9 

Dated: February 5, 2007. 

Joan F. Karr, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E7–2177 Filed 2–8–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare and Medicaid 

Services 

[Document Identifier: CMS–R–262 and 

CMS–10142] 

Emergency Clearance: Public 

Information Collection Requirements 

Submitted to the Office of Management 

and Budget 

AGENCY: Center for Medicare and 

Medicaid Services. 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Centers for Medicare and Medicaid 

Services (CMS), Department of Health 

and Human Services, is publishing the 

following summary of proposed 

collections for public comment. 

Interested persons are invited to send 

comments regarding this burden 

estimate or any other aspect of this 

collection of information, including any 

of the following subjects: (1) The 

necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions; 

(2) the accuracy of the estimated 

burden; (3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) the use of 

automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

We are, however, requesting an 

emergency review of the information 

collection referenced below. In 

compliance with the requirement of 

section 3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995, we have 

submitted to the Office of Management 

and Budget (OMB) the following 

requirements for emergency review. We 

are requesting an emergency review 

because the collection of this 

information is needed before the 

expiration of the normal time limits 

under OMB’s regulations at 5 CFR Part 

1320. This is necessary to ensure 

compliance with an initiative of the 

Administration. CMS does not have 

sufficient time to complete the normal 

PRA clearance process while making 

corrections and enhancements to the 

software and ensuring that organizations 

have ample time to complete and 

submit their tools by the statutory 

deadline in June 2007. The normal PRA 

clearance process would result in 

violating this statutory deadline which 

would prevent Medicare Advantage 

(MA) and Prescription Drug Plan (PDP) 

organizations from providing benefits to 

millions of Medicare beneficiaries. 

CMS is requesting to continue its use 

of the Plan Benefit Package software, 

formulary and Bid Pricing Tool for the 

collection of benefits, pricing and 

related information for CY 2008 as part 

of the annual bidding process. 

1. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: Plan Benefit 

Package (PBP) and Formulary 

Submission for Medicare Advantage 

(MA) Plans and Prescription Drug Plans 

(PDPs); Use: Under the Medicare 

Modernization Act (MMA), Medicare 

Advantage (MA) and Prescription Drug 

Plan (PDP) organizations are required to 

submit plan benefit packages for all 

Medicare beneficiaries residing in their 

service area. CMS requires that MA and 

PDP organizations submit a completed 

formulary and PBP as part of the annual 

bidding process. During this process, 

organizations prepare their proposed 

plan benefit packages for the upcoming 

contract year and submit them to CMS 

for review and approval. The changes to 

the PBP include enhancements to the 

software for describing the out-ofnetwork benefits, Medicare Savings 

Account (MSA) benefits, Point of 

Service (POS) benefits, Visitor/Travel 

benefits, and collecting Medicare Rx 

information on gap coverage. The 

changes to the formulary include 

enhancements to the submission 

process by developing a drug reference 

table and by collecting excluded drug 

indicators, specialty drug indicators, 

and drug types. The software is more 

clarifying for the plans to describe its 

benefits and for the beneficiaries to 

understand their coverage; Form 

Number: CMS–R–262 (OMB#: 0938–

0763); Frequency: Yearly; Affected 

Public: Business or other for-profit and 

Not-for-profit institutions; Number of 

Respondents: 450; Total Annual 

Responses: 4,725; Total Annual Hours: 

10,800. 

2. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: Bid Pricing Tool 

(BPT) for Medicare Advantage (MA) 

Plans and Prescription Drug Plans 

(PDPs); Use: Under the Medicare 

Prescription Drug, Improvement, and 

Modernization (MMA), Medicare 

Advantage organizations (MAO) and 

Prescription Drug Plans (PDP) are 

required to submit an actuarial pricing 

‘‘bid’’ for each plan offered to Medicare 

beneficiaries. CMS requires that MAOs 

and PDPs complete the BPT as part of 

the annual bidding process. During this 

process, organizations prepare their 

proposed actuarial bid pricing for the 

upcoming contract year and submit 

them to CMS for review and approval. 

The purpose of the BPT is to collect the 

actuarial pricing information for each 

plan. The BPT calculates the plan’s bid, 

enrollee premiums, and payment rates. 

The BPT revisions include structural 

changes to the MA worksheets and 

changes to streamline reporting 

requirements. Form Number: CMS–

10142 (OMB#: 0938–0944); Frequency: 

Yearly; Affected Public: Business or 

other for-profit and Not-for-profit 

institutions; Number of Respondents: 

550; Total Annual Responses: 6,050; 

Total Annual Hours: 42,350. 

CMS is requesting OMB review and 

approval of these collections by March 

21, 2007, with a 180-day approval 

period. Written comments and 

recommendation will be considered 

from the public if received by the 

individuals designated below by March 

3, 2007. 

To obtain copies of the supporting 

statement and any related forms for the 

proposed paperwork collections 

referenced above, access CMS’ Web Site 

address at http://www.cms.hhs.gov/ 

PaperworkReductionActof1995 or EVerDate Aug<31>2005 21:06 Feb 08, 2007 Jkt 211001 PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 E:\FR\FM\09FEN1.SGM 09FEN1

jlentini on PROD1PC65 with NOTICES
6248 Federal Register / Vol. 72, No. 27 / Friday, February 9, 2007 / Notices 

mail your request, including your 

address, phone number, OMB number, 

and CMS document identifier, to 

Paperwork@cms.hhs.gov, or call the 

Reports Clearance Office on (410) 786–

1326. 

Interested persons are invited to send 

comments regarding the burden or any 

other aspect of these collections of 

information requirements. However, as 

noted above, comments on these 

information collection and 

recordkeeping requirements must be 

mailed and/or faxed to the designees 

referenced below by March 3, 2007: 

Centers for Medicare and Medicaid 

Services, Office of Strategic 

Operations and Regulatory Affairs, 

Room C4–26–05, 7500 Security 

Boulevard,Baltimore, MD 21244–

1850, Attn: Bonnie L Harkless; and, 

OMB Human Resources and Housing 

Branch, Attention: Carolyn Lovett, 

New Executive Office Building, Room 

10235, Washington, DC 20503. 

Dated: February 2, 2007. 

Michelle Shortt, 

Director, Regulations Development Group, 

Office of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 07–577 Filed 2–8–07; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, Center 

Review Committee. 

Date: February 19, 2007. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Ritz-Carlton Hotel at Pentagon City, 

1250 South Hayes Street, Arlington, VA 

22202. 

Contact Person: Rita Liu, PhD, Associate 

Director, Office of Extramural Affairs, 

National Institute on Drug Abuse, NIH, 

DHHS, Room 212, MSC 8401, 6101 Executive 

Boulevard, Bethesda, MD 20892–8401, (301) 

435–1388, rliu@nida.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, NIDA/ 

L Conflicts. 

Date: March 5, 2007. 

Time: 2 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Marriott Metro Center, 775 12th 

Street NW., Washington, DC 20005. 

Contact Person: Mark R. Green PhD, 

Deputy Director, Office of Extramural Affairs, 

National Institute on Drug Abuse, NIH, 

DHHS, Room 220, MSC 8401, 6101 Executive 

Boulevard, Bethesda, MD 20892–8401, (301) 

435–1431, mgreen1@nida.nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, NIDA–

F Conflicts. 

Date: March 6, 2007. 

Time: 2 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Gaithersburg Marriott 

Washingtonian Center, 9751 Washingtonian 

Boulevard, Gaithersburg, MD 20878. 

Contact Person: Gerald L. McLaughlin, 

PhD, Scientific Review Administrator, Office 

of Extramural Affairs, National Institute on 

Drug Abuse, NIH, DHHS, Room 220, MSC 

8401, 6101 Executive Boulevard, Bethesda, 

MD 20892–8401, (301) 402–6626, 

gm145a@nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, NIDA–

E Conflicts. 

Date: March 6–7, 2007. 

Time: 2 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Gaithersburg Marriott 

Washingtonian Center, 9751 Washingtonian 

Boulevard, Gaithersburg, MD 20878. 

Contact Person: Gerald L. McLaughlin, 

PhD, Scientific Review Administrator, Office 

of Extramural Affairs, National Institute on 

Drug Abuse, NIH, DHHS, Room 220, MSC 

8401, 6101 Executive Blvd., Bethesda, MD 

20892–8401, (301) 402–6626, 

gm145a@nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel NIDA/K 

Conflicts. 

Date: March 13, 2007. 

Time: 5 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel, 8120 Wisconsin 

Ave., Bethesda, MD 20814. 

Contact Person: Mark Swieter, PhD, Chief, 

Training and Special Projects Review Branch, 

Office of Extramural Affairs, National 

Institute on Drug Abuse, NIH, DHHS, 6101 

Executive Boulevard, Suite 220, Bethesda, 

MD 20892–7491, (301) 435–1389, 

ms80x@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.279, Drug Abuse and 

Addition Research Programs, National 

Institutes of Health, HHS) 

Dated: February 5, 2007. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–592 Filed 2–8–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HOMELAND 

SECURITY 

Federal Emergency Management 

Agency 

[FEMA–3270–EM] 

Colorado; Amendment No. 2 to Notice 

of an Emergency Declaration 

AGENCY: Federal Emergency 

Management Agency, DHS. 

ACTION: Notice. 

SUMMARY: This notice amends the notice 

of an emergency declaration for the 

State of Colorado (FEMA–3270-EM), 

dated January 7, 2007, and related 

determinations. 

DATES: Effective Date: January 31, 2007. 

FOR FURTHER INFORMATION CONTACT: 

Magda Ruiz, Recovery Division, Federal 

Emergency Management Agency, 

Washington, DC 20472, (202) 646–2705. 

SUPPLEMENTARY INFORMATION: The notice 

of an emergency declaration for the 

State of Colorado is hereby amended to 

include the following area among those 

areas determined to have been adversely 

affected by the catastrophe declared an 

emergency by the President in his 

declaration of January 7, 2007: 

Teller County for emergency protective 

measures (Category B), including snow 

removal, under the Public Assistance 

program for any continuous 48-hour period 

during or proximate to the incident period. 

(The following Catalog of Federal Domestic 

Assistance Numbers (CFDA) are to be used 

for reporting and drawing funds: 97.030, 

Community Disaster Loans; 97.031, Cora 

Brown Fund Program; 97.032, Crisis 

Counseling; 97.033, Disaster Legal Services 

Program; 97.034, Disaster Unemployment 

Assistance (DUA); 97.046, Fire Management 

Assistance; 97.048, Individuals and 

Households Housing; 97.049, Individuals and 

Households Disaster Housing Operations; 

97.050 Individuals and Households 

Program—Other Needs; 97.036, Public 

Assistance Grants; 97.039, Hazard Mitigation 

Grant Program.) 

R. David Paulison, 

Under Secretary for Federal Emergency 

Management and Director of FEMA. 

[FR Doc. E7–2145 Filed 2–8–07; 8:45 am] 

BILLING CODE 9110–10–P 


jlentini on PROD1PC65 with NOTICES